# Placebo-controlled Study of Single and Multiple Ascending Doses of UDP-003 in Healthy Human Participants and Patients

> **NCT06813339** · EARLY_PHASE1 · RECRUITING · sponsor: **Cyclarity Therapeutics, Inc.** · enrollment: 84 (estimated)

## Conditions studied

- Atherosclerotic Cardiovascular Disease
- Acute Coronary Syndromes

## Interventions

- **DRUG:** UDP-003
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06813339
- **Lead sponsor:** Cyclarity Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-02-25
- **Primary completion:** 2026-07-30
- **Final completion:** 2027-06-30
- **Target enrollment:** 84 (ESTIMATED)
- **Last updated:** 2026-02-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06813339

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06813339, "Placebo-controlled Study of Single and Multiple Ascending Doses of UDP-003 in Healthy Human Participants and Patients". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06813339. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*